INDSWFTLTD

Ind-Swift Limited has informed the Exchange that the board of directors of the company in their meeting held on April 20, 2005 has approved the :1) Stock Split i.e. sub-division of every equity share of Rs. 10/- each into 5 equity shares of Rs. 2/- each and 2) May 06, 2005 as the record date for the purpose of sub-division of equity shares of the company.

Ind-Swift Limited has informed the Exchange that the Board of Directors in their meeting held on March 31, 2005 have appointed Mr. Ravinder Kumar as a Company Secretary and Compliance Officer of the Company in place of Mr. Nitin Bansal w.e.f. April 1, 2005.

Ind-Swift Limited has informed the Exchange that Essix Biosciences Limited have acquired 3,63,000 Equity Shares aggregating to 4.99% of the share capital of Ind-Swift Limited on March 31, 2005. The mode of acquisition is Preferential Allotment (Allotment of equity shares upon conversion of Zero Coupon Optionally Convertible Warrants) and the shareholding of Essix Biosciences Limited after the said acquisition is 6,05,068 equity shares aggregating to 8.32% of the share capital of Ind-Swift Limited.

Ind-Swift Limited has informed the Exchange that the Board of Directors in their meeting held on March 31, 2005 have allotted 11,60,00 Equity Shares upon conversion of 11,60,000 Zero Coupon Optionally Convertible Warrants as per the following details : 1) 3,63,000 Equity Shares allotted to Promoter upon conversion of 3,63,000 Zero Coupon Optionally Convertible Warrants. 2) 7,97,000 Equity Shares allotted to outside Bodies Corporate upon conversion of 7,97,000 Zero Coupon Optionally Convertible Warrants.

Ind-Swift Limited has informed the Exchange that the Board of Directors in their meeting held on March 23,2005 have approved the stock split i.e. sub - division of every equity shares of face value of Rs. 10/- each into 5 shares of face value of Rs. 2/- each and consequential changes in Memorandum & Articles of Association of the company. The above matter is subject to the approval of shareholders. For the said purpose, it has been decided to convene an EGM of the shareholders of the company on April 20,2005 to obtain their approvals.

Ind-Swift Limited has informed the Exchange that the company has issued a press release dated January 22, 2005 titled 'Ind-Swift net zooms 358% in Q3.' The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Ind-Swift Limited has informed the Exchange that the BODs of the company in the meeting held on Novemebr 30,2004,have alloted:1)8,50,000 Zero Coupon Optionally Convertible Warrants to the promoters/directors of the company;and 2)6,50,000 Zero Coupon Optionally Convertible Warrants to the outside Bodies Corporate.

Ind-Swift Limited has informed the Exchange that the members of the company in their EGM held on November 16, 2004 have approved the issue of 15,00,000 warrants convertible into Equity Shares on Preferential basis to the promoters and outside bodies corporate.

Ind-Swift Limited has informed the Exchange that the Company has issued a press release titled 'Ind-Swift Limited launches Novel drug delivery (NDDS) of Nitazoxanide - set to enter the World Market worth US$ 8 bn of Drugs based on NDDS segments'. The details of the press release issued by the Company shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Ind-Swift Limited has informed the Exchange that at its meeting held on October 16, 2004 the BOD have approved the further issue of 15,00,000 warrants convertible into equity shares on preferential basis to promoters and outside bodies corporate. The allotment shall be subject to the provisions of Section 81(1A) of the Companies Act, 1956 read with SEBI (Disclosures and Investor Protection) Guidelines on preferential allotment. An EGM is now proposed to be convened on November 16, 2004 for the aforesaid purpose.